OR WAIT null SECS
October 03, 2019
Manufacturing of the cell line will take place at Lonza’s GMP facility in Geleen, Netherlands.
October 02, 2019
The new incubators are set to be operational starting in 2021.
Researchers used advanced animal model lab tests to determine the new vector is 10 times more efficient at incorporating corrective genes into bone marrow stem cells than traditional vectors.
Automated, electronic systems for raw materials tracking improve efficiency and prevent mistakes in biopharma manufacturing.
September 19, 2019
The new program, Cornerstone, integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of gene therapy medicinal products.
September 16, 2019
The venture will focus on single-use and modular systems designed to develop novel biotherapeutics.
September 13, 2019
TrakCel and McKesson have formed a collaboration that is aimed at accelerating commercialization of cell and gene therapies by leveraging services to enable a more efficient development pathway.
September 11, 2019
The companies plan to create a new curriculum focusing on single-use applications training, cell therapy technology, process efficiency strategies, process development methodologies, and chromatography proficiency.
September 02, 2019
Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies.
August 23, 2019
Innovate UK has awarded a grant worth thousands to the Atelerix Consortium for the collaborative work with the Cell and Gene Therapy Catapult and Rexgenero on development of cell stabilization technology.